The legacy of the blue pill offers a intricate case study for investors eyeing pharma. While early sales were astounding, current patent lapse and the arrival of generic versions have considerably impacted https://tessnwil395403.theideasblog.com/41498107/the-blue-pill-and-pharma-a-precarious-bet